Search Results 71-80 of 16254 for monoclonal antibody
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
Monoclonal antibodies, such as pembrolizumab, may ... Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2.
Monoclonal antibodies, such as varlilumab and nivolumab, may work by ... History of severe hypersensitivity reaction to any monoclonal antibody.
This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This drug helps reduce relapses of MS by ...
The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...
Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Fraker JL, Clune CG, Sahni SK ...
Further research is underway to identify other potential targets for asthma monoclonal antibody therapy. For more information. Benralizumab (Fasenra) for ...
Eculizumab-aagh injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...
Eculizumab-aeeb injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.